Back to search results

Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer

Abroad (travel likely)Recruiting

Conditions

Breast Adenocarcinoma · HER2-Positive Breast Carcinoma · Anatomic Stage I Breast Cancer AJCC v8 · Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage III Breast Cancer AJCC v8 · Anatomic Stage IV Breast Cancer AJCC v8

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Mayo Clinic in Florida, Jacksonville, Florida, United States

    Contact: Study coordinator (Clinical Trials Referral Office) · mayocliniccancerstudies@mayo.edu · 855-776-0015
    Contact: Principal Investigator (Saranya Chumsri, MD)
Study leads

  • Saranya Chumsri, MD

    Principal Investigator

    Mayo Clinic

View source on ClinicalTrials.gov(opens in a new tab)